SCHEMBL7813672

SCHEMBL7813672

CC(C)C[C@H](NC(=O)c1cccs1)C(=O)NC(NC(=O)Cc1cccc(-c2ccccn2)c1)C(C)O

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HSPA5 P11021 4/20 0.49
▸ HSPA2 P54652 2/20 0.49
▸ CTSL P07711 5/20 0.44
▸ CTSB P07858 2/20 0.44
▸ CTSS P25774 2/20 0.44
▸ HSPA1A P0DMV8 1/20 0.41
▸ HSPA9 P38646 1/20 0.41
▸ CTSK P43235 5/20 0.41
▸ PSMB5 P28074 1/20 0.40
▸ HPGD P15428 1/20 0.38
▸ SCN9A Q15858 1/20 0.38
▸ CNR2 P34972 1/20 0.37
▸ F2 P00734 1/20 0.37
▸ F10 P00742 1/20 0.37
▸ PRSS1 P07477 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ UTS2R Q9UKP6 1/20 0.37
▸ CTSD P07339 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7806106 0.89 HSPA5 (0.49) HSPA5HSPA2CTSLCTSBCTSS
SCHEMBL6620163 0.86 HSPA5 (0.49) HSPA5HSPA2CTSLCTSBCTSS
SCHEMBL7609373 0.85 HSPA5 (0.49) HSPA5HSPA2CTSLCTSBCTSS
SCHEMBL7819471 0.82 REN (0.47) CTSLCTSBCTSSCTSKCTSD
SCHEMBL7470442 0.73 CTSL (0.47) CTSLCTSBCTSSCTSKPSMB5
SCHEMBL7830243 0.73 CTSK (0.39) CTSLCTSBCTSSCTSKSCN9A
SCHEMBL14345770 0.73 TAS1R3 (0.50) CTSLCTSBCTSSCTSKCNR2
SCHEMBL7467592 0.72 TAS1R3 (0.49) CTSLCTSBCTSSCTSKCNR2
SCHEMBL7612563 0.72 CTSL (0.37) HSPA5HSPA2CTSLCTSBCTSS
SCHEMBL7463889 0.72 CTSL (0.49) CTSLCTSBCTSSCTSKPSMB5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1068304-A4 TREATMENT OF PARASITIC DISEASES BY INHIBITION OF CYSTEINE PROTEASES OF THE PAPAIN SUPERFAMILY SMITHKLINE BEECHAM CORP (US) 2001-05-09 — — EP disclosed
EP-1068304-A1 TREATMENT OF PARASITIC DISEASES BY INHIBITION OF CYSTEINE PROTEASES OF THE PAPAIN SUPERFAMILY SMITHKLINE BEECHAM CORPORATION (US) 2001-01-17 — — EP disclosed
WO-1999053039-A1 TREATMENT OF PARASITIC DISEASES BY INHIBITION OF CYSTEINE PROTEASES OF THE PAPAIN SUPERFAMILY SMITHKLINE BEECHAM CORPORATION (US) 1999-10-21 — — WO disclosed
Send feedback